Citigroup »

Sagimet Biosciences Inc-a shares owned by Citigroup

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 5.0k 5.42
2023-12-31 $4.7k 858 5.42

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a